And tracking your results week by week helps you and your provider determine whether the compounded version is working as expected
The cag + tirz combination covers three pathways instead of two, but it has no human trial data of its own
For patients who are needle-averse, who have difficulty adhering to strict dosing windows, or whose weight management goals do not require reductions of 20% or more, an oral GLP-1 weight loss regimen may be a well-matched and more sustainable choice
Studies relying on the HADS may report lower sensitivity for detecting minor depressive symptoms compared to the BDI-II or PHQ-9 (Hu et al., 2021)
This product has not been evaluated and verified by the South African Health Products Regulatory Authority for its quality, safety or intended use
This article is not a guide for the safe and effective use of the medications and is not meant to replace consultation with a health care provider